2Jemail A, Thomas A, Murray T, et al. Cancer statistics. CA Cancer J Clin, 2002,52 : 23-47.
3Sun TT, Liang FX, Wu XR. Uroplakins as markers of urothelial differentiation. Adv Exp Med Biol, 1999,462 : 7-18.
4Negrete HO, Lavelle JP, Berg J. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol, 1996, 271 :886-894.
5Wu XR, Medina JJ, Sun TT. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily,with distinct single transmembrane domained proteins in differentiated urothelial ceils. J Bio Chem, 1995,270 : 29752 -29759.
6Kaufmann O, Volmefig J, Dietel M. Uroplakin III is a highly specific and moderately seneitic immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol, 2000, 113 : 683-687.
7Moll R, Wu XR, Lin JH, et al. Uroplakins specific membrane proteins of urothelial umbrella cells as histological markers of metastatic transitional cell carcinomas. Am J Pathology, 1995,147 : 1383-1397.
8Yuasa T, Yoshiki T, Isono T, et al. Expression of transitional cell specific genes uroplakin Ia and Ⅱ in bladder cancer detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Uro|,1999,6:286-292.
9Yuasa T, Yoshiki T, Tanaka T, et al. Expression of uroplakin Ib and Ⅲ genes in tissues and peripheral blood of patients with transitional cell carcinoma. Jpn J Cancer Res, 1998,89:897-882.
10Li SM ,Zhang ZT,Chan S,et al. Detection of circulating uroplakin positive cells in patients with transitional cell carcinoma of the bladder. J Urol, 1999,162:931-935.
